Re Search Pharmaceutical Service is categorized under Employment Agencies and Opportunities in Blue Bell, PA and active since 2010.
Re Search Pharmaceutical Service was established in 2010, and today employs 1 to 4, earning Unknown per year. This is a Employment Agencies and Opportunities business, which does work in the B2B market, and is classified as a Employment Agencies and Opportunities, under code number 5419100 by the NAICS.
If you are seeking more information, feel free to contact Robert Acuff at the company’s branch by writing to 725 Skippack Pike, Blue Bell, Pennsylvania PA 19422 or by phoning (215) 540-0770. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Re Search Pharmaceutical Service |
| Contact Person: | Robert Acuff |
| Address: | 725 Skippack Pike, Blue Bell, Pennsylvania 19422 |
| Phone Number: | (215) 540-0770 |
| Annual Revenue (USD): | Unknown |
| Founded: | 2010 |
| Location Type: | Branch |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Employment Agencies and Opportunities |
| SIC Code: | 7361 |
| NAICS Code: | 5419100 |
| Share This Business: |
Re Search Pharmaceutical Service was started in 2010 to provide professional Employment Agencies and Opportunities under the SIC code 7361 and NAICS code 5419100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Robert Acuff for inquiries that concern Re Search Pharmaceutical Service by calling the company number (215) 540-0770, as your correspondence is most welcome. Additionally, the physical location of the branch of Re Search Pharmaceutical Service can be found at the coordinates 40.15465,-75.26982 as well as the street address 725 Skippack Pike in Blue Bell, Pennsylvania 19422.
For its online presence, you may visit Re Search Pharmaceutical Service’s website at and engage with its social media outlets through on Twitter and on Facebook.